Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry
American Heart Journal2024cited by 19position: middledoi
Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings
Advances in Therapy2024cited by 8position: middledoi
Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline
American Heart Journal Plus Cardiology Research and Practice2022cited by 14position: middledoi